Ep. 552: Frankly Speaking: Buy This Small Cap Biotech “Steal” Right Now

In this and every episode of Frankly Speaking, we discuss your top questions about the markets, stocks, the economy – even sports.

This week (09/15/2017):

A safe cyber-security play… The best way to buy stocks on the TSX (Toronto Stock Exchange)… Another small cap biotech steal

  1. “It’s been over a week since the Equifax (EFX) data breach and the stock has beaten down by roughly 25%. Should we buy the dip? …Or is there still more pain to come?” – Anthony [00:46]
  2. “Can you quickly recommend a few online brokers that are capable of trading stocks directly on the TSX?” – John [12:11]
  3. “Is Advaxis (ADXS) dead? They have a premier drug in phase 3, with a couple others in early clinical stages, but the stock is in a free-fall as of late. What are Wall Street’s expectations?” – Chad [16:39]
  4. “Are the Eagles for real this year?” – Dale [33:34]

As always, thanks to everyone who participated!

Ask me anything by emailing me at Frank@CurzioResearch (with “Frankly Speaking” in the subject line). You never know, your question may be the one I read on the next podcast!

Good Investing,

Frank Curzio

Stocks mentioned


uranium market

Is there finally certainty for the uranium market?

After 18 long months, President Trump has rejected the Section 232 petition to impose quotas on uranium imports. Going against the advice of the Commerce Department, he did something else instead… Arthur Hyde of Segra Resource Partners uranium fund joins Mike to discuss the possible implications.
Listen Now
quant investing

Meb Faber unplugged

Meb Faber, CEO and chief investment officer of Cambria Investment Management, breaks down “quant” investing… his thoughts on today’s markets... and the best investing opportunity you can take advantage of right now.
Listen Now